Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Meda
Deals
Can Mylan grow without M&A?
Mylan thought a series of recent deals would deliver future growth, but it's facing new pressures now—and may just have to rely on more M&A.
Eric Sagonowsky
May 11, 2017 10:59am
Mylan closes Illinois plant, cuts 90 jobs after Meda buyout
Mar 28, 2017 9:54am
Worried about the 2016 election, pharma took an M&A break
Feb 22, 2017 10:02am
Mylan eyes thousands of layoffs in post-M&A revamp
Dec 7, 2016 8:19am
Mylan to shutter Meda's HQ in New Jersey, cut loose 94 workers
Oct 31, 2016 2:34pm
Celgene boosts Q2 sales by whopping 22%; Shire raises guidance, citing Vyvanse, Firazyr sales; Amgen files for new Kyprolis use;
Jul 23, 2015 11:28am